The Petersen prognostic index revisited in Dukes B colon cancer - Inter-institutional differences

G. Cserni, R. Bori, István Sejben, Emese I. Ágoston, Balázs Ács, A. Szász

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A prognostic index (Petersen index, PI) was created for patients with pT3-4 pN0 M0 (Stage II, Dukes' B) colon cancers to distinguish between patients with better and worse outcome, and to help in recommending adjuvant chemotherapy for high risk patients in this stage.The prognostic value of the PI was evaluated in two independent retrospective series of stage II (Dukes' B) colon cancer patients. The parameters defining the PI (venous invasion, peritoneal involvement, circumferential margin involvement, perforation through the tumour) and performance of the PI were compared in two institutions.The two series of patients consisted of 127 and 87 patients. Venous invasion was more frequently detected at one of the centres (p <0.01) and tumour perforation was more frequent at the other (p <0.01). There were no significant differences in the 5-year survival estimates of all patients (p = 0.19), and of either the low PI value groups (p = 0.52) or that of the high PI value groups (p = 0.99) between the two sites. In contrast, there were significant differences in the survival estimates between patients of the low PI category and those of the high PI category altogether (p <0.01) and in either centre.Although, it was expected that differences in the frequency of the parameters involved in the PI would influence its performance, this was not confirmed by the data. Our results suggest that using the PI may be of value in prognostic factor based therapy selection of colon carcinoma patients.

Original languageEnglish
Pages (from-to)73-76
Number of pages4
JournalPathology Research and Practice
Volume212
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Colonic Neoplasms
Survival
Adjuvant Chemotherapy
Neoplasms
Colon
Carcinoma

Keywords

  • Colon cancer
  • Dukes' B
  • Prognostic index
  • Stage II

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

The Petersen prognostic index revisited in Dukes B colon cancer - Inter-institutional differences. / Cserni, G.; Bori, R.; Sejben, István; Ágoston, Emese I.; Ács, Balázs; Szász, A.

In: Pathology Research and Practice, Vol. 212, No. 2, 01.02.2016, p. 73-76.

Research output: Contribution to journalArticle

@article{418748e08dbc42adb99642c35efacd4a,
title = "The Petersen prognostic index revisited in Dukes B colon cancer - Inter-institutional differences",
abstract = "A prognostic index (Petersen index, PI) was created for patients with pT3-4 pN0 M0 (Stage II, Dukes' B) colon cancers to distinguish between patients with better and worse outcome, and to help in recommending adjuvant chemotherapy for high risk patients in this stage.The prognostic value of the PI was evaluated in two independent retrospective series of stage II (Dukes' B) colon cancer patients. The parameters defining the PI (venous invasion, peritoneal involvement, circumferential margin involvement, perforation through the tumour) and performance of the PI were compared in two institutions.The two series of patients consisted of 127 and 87 patients. Venous invasion was more frequently detected at one of the centres (p <0.01) and tumour perforation was more frequent at the other (p <0.01). There were no significant differences in the 5-year survival estimates of all patients (p = 0.19), and of either the low PI value groups (p = 0.52) or that of the high PI value groups (p = 0.99) between the two sites. In contrast, there were significant differences in the survival estimates between patients of the low PI category and those of the high PI category altogether (p <0.01) and in either centre.Although, it was expected that differences in the frequency of the parameters involved in the PI would influence its performance, this was not confirmed by the data. Our results suggest that using the PI may be of value in prognostic factor based therapy selection of colon carcinoma patients.",
keywords = "Colon cancer, Dukes' B, Prognostic index, Stage II",
author = "G. Cserni and R. Bori and Istv{\'a}n Sejben and {\'A}goston, {Emese I.} and Bal{\'a}zs {\'A}cs and A. Sz{\'a}sz",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.prp.2015.08.006",
language = "English",
volume = "212",
pages = "73--76",
journal = "Pathology Research and Practice",
issn = "0344-0338",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "2",

}

TY - JOUR

T1 - The Petersen prognostic index revisited in Dukes B colon cancer - Inter-institutional differences

AU - Cserni, G.

AU - Bori, R.

AU - Sejben, István

AU - Ágoston, Emese I.

AU - Ács, Balázs

AU - Szász, A.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - A prognostic index (Petersen index, PI) was created for patients with pT3-4 pN0 M0 (Stage II, Dukes' B) colon cancers to distinguish between patients with better and worse outcome, and to help in recommending adjuvant chemotherapy for high risk patients in this stage.The prognostic value of the PI was evaluated in two independent retrospective series of stage II (Dukes' B) colon cancer patients. The parameters defining the PI (venous invasion, peritoneal involvement, circumferential margin involvement, perforation through the tumour) and performance of the PI were compared in two institutions.The two series of patients consisted of 127 and 87 patients. Venous invasion was more frequently detected at one of the centres (p <0.01) and tumour perforation was more frequent at the other (p <0.01). There were no significant differences in the 5-year survival estimates of all patients (p = 0.19), and of either the low PI value groups (p = 0.52) or that of the high PI value groups (p = 0.99) between the two sites. In contrast, there were significant differences in the survival estimates between patients of the low PI category and those of the high PI category altogether (p <0.01) and in either centre.Although, it was expected that differences in the frequency of the parameters involved in the PI would influence its performance, this was not confirmed by the data. Our results suggest that using the PI may be of value in prognostic factor based therapy selection of colon carcinoma patients.

AB - A prognostic index (Petersen index, PI) was created for patients with pT3-4 pN0 M0 (Stage II, Dukes' B) colon cancers to distinguish between patients with better and worse outcome, and to help in recommending adjuvant chemotherapy for high risk patients in this stage.The prognostic value of the PI was evaluated in two independent retrospective series of stage II (Dukes' B) colon cancer patients. The parameters defining the PI (venous invasion, peritoneal involvement, circumferential margin involvement, perforation through the tumour) and performance of the PI were compared in two institutions.The two series of patients consisted of 127 and 87 patients. Venous invasion was more frequently detected at one of the centres (p <0.01) and tumour perforation was more frequent at the other (p <0.01). There were no significant differences in the 5-year survival estimates of all patients (p = 0.19), and of either the low PI value groups (p = 0.52) or that of the high PI value groups (p = 0.99) between the two sites. In contrast, there were significant differences in the survival estimates between patients of the low PI category and those of the high PI category altogether (p <0.01) and in either centre.Although, it was expected that differences in the frequency of the parameters involved in the PI would influence its performance, this was not confirmed by the data. Our results suggest that using the PI may be of value in prognostic factor based therapy selection of colon carcinoma patients.

KW - Colon cancer

KW - Dukes' B

KW - Prognostic index

KW - Stage II

UR - http://www.scopus.com/inward/record.url?scp=84957650986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957650986&partnerID=8YFLogxK

U2 - 10.1016/j.prp.2015.08.006

DO - 10.1016/j.prp.2015.08.006

M3 - Article

VL - 212

SP - 73

EP - 76

JO - Pathology Research and Practice

JF - Pathology Research and Practice

SN - 0344-0338

IS - 2

ER -